Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device prostrate cancer genes nucleic acid amplification test system
Definition An in vitro nucleic acid amplification test that measures the concentration of prostate cancer genes.
Product CodeOYM
Device Class 3

Premarket Approvals (PMA)
2020 2021 2022 2023 2024 2025
2 0 0 0 0 0

-
-